Document is current
Any future updates will be listed below
-
Authors
Ayers, Dieter
Cope, Shannon
Towle, Kevin
Mojebi, Ali
Marshall, Thomas
Dhanda, Devender
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb
- License Information
-
More Information
Article History
Received: 16 February 2022
Accepted: 30 September 2022
First Online: 15 October 2022
Declarations
:
: This study was conducted in accordance with the international council for harmonization guidelines for Good Clinical Practice and the principles of Declaration of Helsinki. Additionally, it was conducted in accordance with the international society for pharmacoepidemiology (ISPE) guidelines for Good Epidemiology Practices.The study protocol, verbal informed consent and waiver of consent documentation were approved by Advarra Institutional Review Board.
: Not applicable.
: DA, SC, KT, and AM are employees of PRECISIONheor. DD and TM are employees of Bristol Myers Squibb, and may hold stock equity.
